I've reached the query_library_db limit. The library searches returned minimal results, so I'll now provide a comprehensive, authoritative answer from my medical knowledge across all 11 pediatric/neonatology topics.
Pediatrics & Neonatology: Comprehensive Topic Guide
1. Respiratory (Pediatric)
Key Conditions
Respiratory Distress Syndrome (RDS) / Hyaline Membrane Disease
- Most common cause of respiratory distress in preterm neonates (<37 weeks), especially <34 weeks
- Pathophysiology: surfactant deficiency → alveolar collapse → ↑ work of breathing, hypoxemia, hypercarbia
- Clinical features: tachypnea, grunting, nasal flaring, subcostal/intercostal retractions, cyanosis within 6 hours of birth
- CXR: ground-glass opacity, air bronchograms, "white-out" in severe cases
- Management:
- Antenatal corticosteroids (betamethasone 12 mg IM × 2 doses, 24h apart) if 24–34 weeks gestation
- Exogenous surfactant (beractant, poractant alfa) — intratracheal
- CPAP or mechanical ventilation
- Oxygen — target SpO₂ 91–95% in preterms
Transient Tachypnea of the Newborn (TTN)
- Most common respiratory disorder in term neonates
- Caused by delayed resorption of fetal lung fluid (especially after C-section)
- Self-limiting within 12–72 hours
- CXR: wet silhouette, perihilar streaking, fluid in fissures
Meconium Aspiration Syndrome (MAS)
- Seen in post-term or stressed term infants
- Pathophysiology: meconium in amniotic fluid → aspiration → ball-valve obstruction, pneumonitis, pulmonary hypertension
- Management: suctioning, surfactant, inhaled NO for pulmonary hypertension, ECMO in refractory cases
Bronchiolitis
- Most common lower respiratory tract infection in infants <2 years
- Most common cause: RSV (Respiratory Syncytial Virus)
- Features: rhinorrhea → cough → wheeze/crackles → respiratory distress
- Management: supportive — oxygen, hydration, high-flow nasal cannula
- Palivizumab: RSV prophylaxis for high-risk infants (preterms <29 weeks, CLD, congenital heart disease)
Pneumonia
- Neonatal: GBS, E. coli, Listeria (early-onset); Staph aureus, Klebsiella (late-onset)
- Infants 1–3 months: Chlamydia trachomatis (staccato cough, no fever, eosinophilia)
- Toddlers/preschool: viral (RSV, parainfluenza, rhinovirus)
- School age+: Mycoplasma pneumoniae ("walking pneumonia")
Cystic Fibrosis (CF)
- Autosomal recessive, CFTR mutation (ΔF508 most common)
- Features: recurrent pulmonary infections, pancreatic exocrine insufficiency, failure to thrive, meconium ileus in neonates, salty sweat
- Diagnosis: newborn screening (IRT), sweat chloride test >60 mmol/L
- Management: physiotherapy, CFTR modulators (ivacaftor, elexacaftor-tezacaftor-ivacaftor), enzyme replacement, antibiotics
2. Nutrition (Pediatric)
Caloric Requirements
| Age | kcal/kg/day |
|---|
| Preterm NICU | 100–130 |
| 0–6 months | 100–110 |
| 6–12 months | 80–100 |
| 1–3 years | 80–90 |
| 4–6 years | 70–80 |
Macronutrients
- Protein: 3–4 g/kg/day (preterm), 1.5–2 g/kg/day (term infant)
- Fat: 50% of calories in breast milk; essential fatty acids (DHA, ARA) critical for brain development
- Carbohydrates: lactose primary source in infants
Routes of Feeding
- Enteral nutrition preferred whenever gut is functional
- Parenteral nutrition (PN): for preterm or ill neonates unable to tolerate enteral feeds
- Provides glucose, amino acids, lipid emulsions (Intralipid), electrolytes, trace elements
- Complications: catheter-related sepsis, cholestasis, hyperglycemia
Malnutrition
- Protein-Energy Malnutrition (PEM):
- Kwashiorkor: protein deficiency, edema, hair changes (flag sign), dermatitis, preserved fat stores, fatty liver
- Marasmus: total caloric deficiency, severe wasting, no edema, very low weight, alert facies
- WHO management: RUTF (Ready-to-Use Therapeutic Food), 10 steps of nutritional rehabilitation
3. Micronutrients
Vitamin A
- Deficiency: xerophthalmia (night blindness → Bitot spots → corneal ulceration → keratomalacia), increased susceptibility to infections
- Supplementation: given at 6, 12, and 18 months in deficiency-endemic areas
- Measles complication: high-dose Vitamin A supplementation (200,000 IU) reduces morbidity/mortality
Vitamin D
- Deficiency → Rickets (nutritional): bowed legs, rachitic rosary, widened wrists, Harrison's groove, craniotabes
- Diagnosis: low 25-OH Vitamin D, low Ca²⁺/PO₄, elevated ALP and PTH
- Treatment: Vitamin D₃ 2,000–4,000 IU/day + calcium supplementation
- All breastfed infants: 400 IU/day Vitamin D supplement from birth
Vitamin C
- Deficiency → Scurvy: perifollicular hemorrhages, corkscrew hairs, bleeding gums, subperiosteal hemorrhage, Frankel lines on X-ray
Vitamin K
- Deficiency → Hemorrhagic Disease of Newborn (Vitamin K Deficiency Bleeding, VKDB)
- Early (0–24h): maternal drugs (anticonvulsants, warfarin)
- Classic (2–7 days): breastfed, no prophylaxis
- Late (2–12 weeks): fat malabsorption, cholestasis
- Prevention: Vitamin K 1 mg IM at birth (0.5 mg if <1,500 g)
Iron (Fe)
Iodine
- Deficiency: congenital hypothyroidism, cretinism (intellectual disability, goiter, stunted growth, deafness)
- Universal salt iodization is primary prevention strategy
Zinc
- Deficiency: impaired wound healing, diarrhea, alopecia, acrodermatitis enteropathica (autosomal recessive, failure to absorb zinc)
- Critical for immune function and growth
Folate
- Deficiency in pregnancy → neural tube defects (spina bifida, anencephaly)
- Supplementation: 400–800 µg/day periconceptionally
4. NICU (Neonatal Intensive Care Unit)
Admission Criteria
- Prematurity <34 weeks, birth weight <1,500 g (VLBW) or <1,000 g (ELBW)
- Respiratory distress, apnea of prematurity
- Neonatal sepsis, meconium aspiration, birth asphyxia
- Surgical conditions (NEC, CDH, esophageal atresia)
Key NICU Problems
Apnea of Prematurity
- Cessation of breathing >20 seconds or shorter with bradycardia/desaturation
- Types: central (no respiratory effort), obstructive (effort but no airflow), mixed (most common)
- Management: methylxanthines (caffeine citrate — drug of choice), CPAP, tactile stimulation
- Caffeine: reduces need for mechanical ventilation, associated with improved neurodevelopmental outcomes
Intraventricular Hemorrhage (IVH)
- Common in VLBW/ELBW preterms
- Grading (Papile classification):
- Grade I: germinal matrix only
- Grade II: IVH without ventricular dilation
- Grade III: IVH with ventricular dilation
- Grade IV: periventricular hemorrhagic infarction (worst prognosis)
- Screening: cranial ultrasound day 3–5 and day 7–10
- Prevention: antenatal steroids, Vitamin K, indomethacin (prophylactic)
Necrotizing Enterocolitis (NEC)
- Most common GI surgical emergency in neonates
- Risk factors: prematurity, formula feeding, hypoxia, polycythemia
- Bell's staging:
- Stage I: suspected (clinical signs, normal/nonspecific X-ray)
- Stage II: confirmed (pneumatosis intestinalis on X-ray)
- Stage III: advanced (perforation — pneumoperitoneum)
- Management: NPO, NG decompression, broad-spectrum antibiotics, surgical resection for perforation/necrosis
- Prevention: breast milk, probiotic supplementation
Neonatal Jaundice / Hyperbilirubinemia
- Physiological: starts day 2–3, peaks day 4–5, resolves by day 10 (term) or day 14 (preterm)
- Pathological: starts <24 hours, rises >5 mg/dL/day, direct bilirubin >2 mg/dL
- Causes: hemolytic (ABO/Rh incompatibility, G6PD), sepsis, metabolic
- Management: phototherapy (AAP curves by gestational age/age in hours), exchange transfusion
Retinopathy of Prematurity (ROP)
- Abnormal retinal vascularization in preterms (<32 weeks, <1,500 g)
- Zonal classification (I, II, III) and staging (1–5)
- Plus disease: vascular dilation + tortuosity
- Screening: dilated fundus exam at 4–6 weeks of age
- Treatment: laser photocoagulation, anti-VEGF (bevacizumab)
Hypothermia / Thermoregulation
- Neonates: poikilothermic, high surface area:mass ratio → rapid heat loss
- Methods of heat loss: radiation, convection, conduction, evaporation
- Management: radiant warmer, incubator, skin-to-skin (kangaroo care)
- Therapeutic hypothermia: for HIE (hypoxic-ischemic encephalopathy) ≥36 weeks, initiated within 6 hours of birth, target 33–34°C for 72 hours
Neonatal Hypoglycemia
- Threshold: blood glucose <47 mg/dL (symptomatic) or <40 mg/dL (neonatal)
- Risk groups: IDM, SGA, preterm, macrosomic infants
- Symptoms: jitteriness, seizures, apnea, hypotonia, lethargy
- Management: early enteral feeding, IV dextrose (D10W 2 mL/kg bolus → infusion)
Neonatal Sepsis
- Early-onset (<72h): GBS, E. coli, Listeria — acquire intrapartum
- Late-onset (>72h): coagulase-negative Staph, Staph aureus, Gram-negative rods
- Workup: CBC, CRP, blood culture, LP (if stable), urine culture
- Empirical treatment: ampicillin + gentamicin (early); vancomycin + aminoglycoside (late)
5. Growth and Development
Physical Growth
Weight
- Birth weight: average 3.0–3.5 kg
- Physiological weight loss 7–10% in first week (regained by day 10–14)
- Doubles by 5 months, triples by 12 months
- 4–6 years: +2 kg/year
Length/Height
- Birth: 50 cm → 75 cm by 12 months → 100 cm by 4 years
- Pubertal growth spurt: girls ~10–11 years, boys ~12–13 years
Head Circumference (OFC)
- Birth: 33–35 cm → +12 cm in first year (half of postnatal growth)
- Anterior fontanelle closes: 9–18 months
- Posterior fontanelle closes: 6–8 weeks
Developmental Milestones
| Age | Gross Motor | Fine Motor | Language | Social |
|---|
| 2 mo | Head control prone | Hands unfisted | Social smile, coos | Recognizes face |
| 4 mo | Rolls front-to-back | Reach, grasp | Laughs, vowels | Responds to voice |
| 6 mo | Sits with support | Transfers hand-to-hand | Babbles | Stranger anxiety begins |
| 9 mo | Cruises, crawls | Pincer grasp developing | "Mama/dada" non-specifically | Object permanence |
| 12 mo | Walks independently | Mature pincer | 1–3 words with meaning | Waves bye |
| 18 mo | Runs | Stacks 4 cubes | 10–20 words | Parallel play |
| 24 mo | Climbs stairs (2 feet/step) | Stacks 6 cubes | 50+ words, 2-word phrases | Parallel play |
| 3 yr | Rides tricycle | Copies circle | 3-word sentences | Group play |
| 4 yr | Hops on one foot | Copies cross | 4-word sentences | Cooperative play |
| 5 yr | Skips | Copies triangle | Full sentences | |
Denver Developmental Screening Test (DDST)
- Screens personal-social, fine motor-adaptive, language, gross motor
- Not diagnostic — identifies children needing further evaluation
Red Flags (Developmental)
- No social smile by 3 months
- No head control by 4 months
- Not sitting unsupported by 9 months
- No words by 16 months, no 2-word phrases by 24 months
- Any regression of milestones at any age
6. Immunization (Pediatric)
EPI Schedule (India / WHO-based)
| Age | Vaccine |
|---|
| Birth | BCG, OPV-0, Hepatitis B-1 |
| 6 weeks | DTP-1, IPV-1, Hep B-2, Hib-1, PCV-1, Rotavirus-1 |
| 10 weeks | DTP-2, IPV-2, Hib-2, PCV-2, Rotavirus-2 |
| 14 weeks | DTP-3, IPV-3, Hib-3, PCV-3, Rotavirus-3 |
| 6 months | OPV-1, Hep B-3 |
| 9 months | MR/MMR-1, Vitamin A-1 |
| 12 months | Hep A-1 |
| 15–18 months | DTP booster-1, OPV-3, MMR-2, Varicella, Hep A-2 |
| 2 years | Typhoid conjugate vaccine (annual) |
| 5 years | DTP booster-2 |
| 10–12 years | Td, HPV (girls) |
Key Points
- BCG: given at birth, protects against disseminated TB, tuberculosis meningitis; Mantoux test may be positive after BCG
- OPV vs IPV: OPV — live attenuated (oral, cheap, herd immunity, risk of VAPP); IPV — inactivated (injectable, no VAPP risk, preferred in India now)
- Cold chain: vaccines stored at 2–8°C (freeze-sensitive: DTP, Hep B, Hib, PCV; freeze-tolerant: OPV, MMR, BCG)
- Contraindications: live vaccines contraindicated in immunocompromised (except HIV with CD4 >25%); MMR contraindicated in egg allergy (anaphylaxis) — actually safe in egg allergy; contraindicated in pregnancy
- Vaccine adverse events: BCG adenitis, febrile seizures post-MMR (day 7–12), intussusception risk post-rotavirus, anaphylaxis
7. Complementary Feeding
Definition
Introduction of solid/semi-solid foods alongside breast milk or formula, beginning at 6 months of age.
WHO Recommendations
- Exclusive breastfeeding for first 6 months
- Complementary feeding introduced at exactly 6 months (not before 4 months)
- Continue breastfeeding up to 2 years or beyond
IYCF Principles (Infant and Young Child Feeding)
- Timely: start at 6 months
- Adequate: sufficient in quantity, quality, nutrient density
- Safe: hygienic preparation, safe storage
- Appropriately fed: responsive feeding, appropriate texture by age
Feeding Progression
| Age | Texture | Frequency | Amount |
|---|
| 6–8 months | Purée/mashed | 2–3 times/day | 2–3 tsp → gradually increase |
| 9–11 months | Finely chopped, mashed | 3–4 times/day | ½ cup (125 mL) |
| 12–24 months | Family foods, chopped | 3–4 times/day + snacks | ¾ cup (175 mL) |
What to Introduce
- Staples (rice, wheat, maize), legumes, vegetables, fruits, animal source foods (meat, egg, fish, dairy)
- Iron-rich foods early (meat, fortified cereals) — critical given iron stores deplete after 6 months
- No added salt, sugar, honey (honey: risk of infant botulism <1 year)
- No cow's milk as main drink before 12 months (may be used in cooking)
Common Mistakes
- Early introduction (<4 months): ↑ risk of allergy, obesity, celiac disease
- Late introduction (>6 months): ↑ risk of iron deficiency, stunting
- Low nutrient density foods: watery porridges (energy-poor)
- Improper hygiene: diarrheal disease
Allergen Introduction
- Current evidence supports early introduction of allergenic foods (peanuts, eggs) at 6 months to reduce sensitization risk (LEAP trial evidence)
- Do not delay introduction of potentially allergenic foods beyond 12 months
8. Breastfeeding and Lactation
Benefits of Breastfeeding
For Infant:
- Protective against: otitis media, respiratory infections, UTI, NEC, SIDS, diarrhea
- Reduces risk of: obesity, type 1 & 2 diabetes, leukemia, asthma, eczema
- Optimal cognitive development (DHA, human milk oligosaccharides, growth factors)
- Passive immunity via sIgA, lactoferrin, lysozyme, macrophages, lymphocytes
For Mother:
- Reduces risk of: breast cancer, ovarian cancer, type 2 diabetes, postpartum hemorrhage (via oxytocin)
- Lactational amenorrhea method (LAM): family planning if exclusive, amenorrheic, <6 months → 98% effective
Composition of Breast Milk
| Component | Colostrum (days 1–3) | Mature Milk |
|---|
| Protein | High (2.3 g/dL) | Lower (0.9 g/dL) |
| Fat | Low | High (~4 g/dL) |
| IgA | Very high | Moderate |
| Calories | ~67 kcal/dL | ~67 kcal/dL |
| Color | Yellow, thick | White |
- Foremilk: watery, high lactose — quenches thirst
- Hindmilk: fat-rich — provides calories; infant must empty breast to receive hindmilk
Lactation Physiology
- Prolactin: milk production (anterior pituitary); peaks with infant suckling
- Oxytocin: milk ejection reflex (let-down); released with suckling, skin-to-skin, hearing cry
- Supply = demand: frequent, effective suckling establishes milk supply
Latch Assessment (LATCH Score)
- Latch, Audible swallowing, Type of nipple, Comfort, Hold — scored 0–2 each
Contraindications to Breastfeeding
- Absolute: maternal HIV in resource-rich settings, infant galactosemia, maternal active TB (untreated <2 weeks), maternal HTLV-1/2, maternal herpes simplex lesion on breast
- Relative/temporary: maternal chemotherapy, certain medications (radioactive isotopes, antineoplastics)
- Note: CMV in mature breast milk is low-risk for term infants; concern only in VLBW preterms
Common Breastfeeding Problems
- Engorgement: frequent feeding, warm compress, proper latch
- Sore nipples: improper latch, Raynaud's phenomenon, candidal infection
- Mastitis: S. aureus most common; continue breastfeeding + antibiotics (dicloxacillin)
- Insufficient milk: reassurance, frequent feeding, ensuring effective latch; domperidone/metoclopramide (galactagogues) — use with caution
- Jaundice: breast milk jaundice (indirect, starts day 7, resolves with continued feeding) vs. breastfeeding failure jaundice (early, improper latch → inadequate intake → dehydration)
9. Cerebral Palsy (CP)
Definition
A group of permanent, non-progressive disorders of movement and posture due to disturbances in the developing fetal or infant brain.
Classification
By Tone/Movement Type:
- Spastic (most common, ~85%): upper motor neuron lesion, ↑ tone, brisk reflexes, scissor gait
- Spastic diplegia: predominantly lower limbs (preterm association)
- Spastic hemiplegia: one side (term, periventricular leukomalacia or MCA stroke)
- Spastic quadriplegia: all 4 limbs (most severe; associated with intellectual disability, seizures)
- Dyskinetic/Athetoid: basal ganglia lesion; choreoathetosis; kernicterus association
- Ataxic: cerebellar; least common; wide-based gait, hypotonia
- Mixed: most common in practice
Etiology
- Prenatal (most common ~75%): genetic, congenital brain malformations, TORCH infections, stroke in utero
- Perinatal: HIE, birth asphyxia, prematurity-related (IVH, PVL), kernicterus
- Postnatal: meningitis, head trauma, encephalitis (<2–3 years)
Associated Conditions (CAMPS mnemonic — Communication, Associated disorders, Motor, Perception, Seizures)
- Epilepsy (30–50%), intellectual disability, visual impairment, hearing loss, speech/language disorders, feeding difficulties, scoliosis, hip dysplasia, pain
Diagnosis
- Clinical: history + neurological exam + developmental assessment
- MRI brain: most useful (PVL, cortical malformations, basal ganglia lesions) — recommended in all cases
- Cranial ultrasound: IVH, PVL in preterm
- EEG if seizures suspected
- Exclude progressive/metabolic conditions if atypical
Management (Multidisciplinary)
- Physiotherapy: range of motion, gait training, orthotics
- Occupational therapy: ADL skills, upper limb function
- Speech therapy: feeding, communication
- Spasticity management:
- Oral: baclofen, diazepam, dantrolene
- Focal: botulinum toxin A injection (most effective for focal spasticity)
- Intrathecal baclofen pump (generalized spasticity)
- Selective dorsal rhizotomy (surgical)
- Seizure management: anticonvulsants per seizure type
- Nutrition: high caloric needs, gastrostomy feeding if severe dysphagia
- Orthopedic surgery: hip reconstruction, tendon lengthening
10. Learning Disorders
Definition
Neurodevelopmental disorders characterized by persistent difficulties in learning academic skills despite adequate instruction, intelligence, and sensory function.
Types (DSM-5)
Dyslexia (reading disorder)
- Most common learning disorder
- Impaired reading accuracy, fluency, comprehension
- Phonological processing deficit (core mechanism)
- Not due to intellectual disability, visual/hearing impairment, inadequate instruction
- Associated with ADHD in 40%
Dysgraphia (writing disorder)
- Impaired written expression: spelling, grammar, punctuation, handwriting
- Not simply poor penmanship; includes difficulties with written composition
Dyscalculia (mathematics disorder)
- Difficulty with number sense, arithmetic, and mathematical reasoning
- Persistent (not explained by instruction or IQ)
ADHD (Attention Deficit Hyperactivity Disorder)
- Prevalence: 5–10% children
- Core features: inattention, hyperactivity, impulsivity — present in ≥2 settings, onset before age 12
- Types: predominantly inattentive, predominantly hyperactive-impulsive, combined
- Diagnosis: clinical (DSM-5 criteria), no lab or imaging required; behavioral rating scales (Conners, Vanderbilt)
- Management:
- First-line medications: methylphenidate (ages 6+), amphetamine salts; stimulants most effective
- Preschool age (4–5 yrs): behavioral therapy first, methylphenidate if severe
- Non-stimulants: atomoxetine (SNRI), guanfacine, clonidine
- School accommodations: extended time, preferential seating, reduced workload
Autism Spectrum Disorder (ASD)
- Persistent deficits in social communication + restricted, repetitive behaviors
- Onset in early development; more common in males (4:1)
- Red flags: no babbling by 12 months, no words by 16 months, no 2-word phrases by 24 months, any regression
- Screening: M-CHAT-R/F at 18 and 24 months
- Diagnosis: ADOS-2, ADI-R (gold standard)
- Management: ABA therapy, speech therapy, OT, social skills training; risperidone/aripiprazole for irritability
Principles of Management (Learning Disorders)
- Early identification and intervention
- Individualized education program (IEP) or 504 plan
- Remediation strategies (phonics-based for dyslexia)
- Accommodation vs. modification
- Psychological support for child and family
- Address comorbidities (anxiety, depression, ADHD)
11. Iron Deficiency Anemia (IDA)
Epidemiology
- Most common nutritional deficiency and cause of anemia worldwide
- Peak age: 6 months–3 years (dietary insufficiency after stores deplete) and adolescent girls (menstrual loss)
Stages of Iron Deficiency
- Iron depletion: ↓ ferritin (storage iron), normal Hb, normal RBCs
- Iron-deficient erythropoiesis: ↓ serum iron, ↑ TIBC, ↓ transferrin saturation, ↑ free erythrocyte protoporphyrin (FEP)
- Iron deficiency anemia: microcytic, hypochromic anemia with all above changes
Etiology in Children
- Inadequate intake: cow's milk excess (>750 mL/day displaces iron-rich foods; low iron content, causes occult GI blood loss), prolonged exclusive breastfeeding without complementary feeding
- Poor absorption: cow's milk protein intolerance, celiac disease, H. pylori
- Increased demand: prematurity, low birth weight, twin pregnancy (depleted stores)
- Blood loss: Meckel's diverticulum, hookworm, inflammatory bowel disease, menorrhagia
Clinical Features
- Hematological: pallor, easy fatigability, tachycardia, high-output cardiac failure (severe)
- Non-hematological (pica, neurocognitive impact are key):
- Pica (eating non-food items)
- Restless leg syndrome
- Cognitive impairment, decreased attention, poor school performance (even with mild ID)
- Spoon-shaped nails (koilonychia), atrophic glossitis, angular stomatitis (severe/chronic)
- Plummer-Vinson syndrome (web + dysphagia + IDA — rare, adult women)
Laboratory Findings
| Parameter | IDA | Finding |
|---|
| Hemoglobin | ↓ | <11 g/dL (6 mo–5 yr), <11.5 g/dL (5–12 yr) |
| MCV | ↓ | Microcytic |
| MCH, MCHC | ↓ | Hypochromic |
| RDW | ↑ | High red cell distribution width |
| Serum iron | ↓ | |
| TIBC | ↑ | |
| Transferrin saturation | ↓ | <15% |
| Ferritin | ↓ | <12 ng/mL |
| Reticulocytes | ↑ | After iron therapy |
| Blood smear | Pencil cells, target cells | |
Differentiation: IDA vs Thalassemia Trait
| Feature | IDA | Beta-thal trait |
|---|
| RDW | ↑ | Normal |
| RBC count | ↓ | Normal/↑ |
| Mentzer index (MCV/RBC) | >13 | <13 |
| Hb electrophoresis | Normal | ↑ HbA₂ (>3.5%) |
| Response to iron | Yes | No |
Treatment
- Dietary: iron-rich foods (red meat, liver, dark leafy greens, fortified cereals), Vitamin C with meals (enhances absorption), avoid cow's milk >500 mL/day
- Therapeutic iron:
- Oral ferrous sulfate: 3–6 mg/kg/day of elemental iron in 2–3 divided doses; given on empty stomach or with Vitamin C
- Continue for 3 months after normalization of Hb (to replenish stores)
- Reticulocytosis peaks at 5–10 days; Hb rises 1 g/dL/week
- IV iron: iron sucrose, ferric carboxymaltose — for malabsorption, intolerance, severe anemia with need for rapid repletion
- Blood transfusion: Hb <5–7 g/dL with cardiovascular compromise; packed RBCs 10 mL/kg slowly
Prevention
- Universal supplementation: all infants 4–6 months (breastfed) or formula with ≥12 mg/L iron
- Preterm/LBW: elemental iron 2 mg/kg/day from 4 weeks of life
- Delayed cord clamping (≥30–60 seconds): increases iron stores by ~30–40 mg
- Avoid introduction of cow's milk before 12 months
- NBS: hemoglobin/ferritin screening at 9–12 months in high-risk
Quick Reference Summary Table
| Topic | Key Organism/Condition | Key Drug/Intervention | Critical Fact |
|---|
| Respiratory | RSV (bronchiolitis) | Palivizumab prophylaxis | CPAP for RDS; surfactant |
| Nutrition | Kwashiorkor/Marasmus | RUTF, PN | 100–130 kcal/kg/day (preterm) |
| Micronutrients | Vit D → Rickets | 400 IU/day (all breastfed) | ALP ↑, Vit D ↓ |
| NICU | RDS, NEC, IVH, ROP | Caffeine, surfactant, laser ROP | Therapeutic hypothermia for HIE |
| Growth/Development | Milestones | Denver screening | Regression = always abnormal |
| Immunization | BCG, DTP, MMR | Cold chain 2–8°C | VAPP risk with OPV |
| Complementary feeding | Iron depletion post-6 mo | Iron-rich foods | No honey <1 year |
| Breastfeeding | sIgA, lactoferrin | Galactagogues PRN | LAM 98% effective |
| Cerebral Palsy | HIE, PVL, kernicterus | Botulinum toxin, baclofen | Non-progressive brain injury |
| Learning disorders | Dyslexia (phonological) | Methylphenidate (ADHD) | M-CHAT at 18 & 24 months |
| IDA | Cow's milk excess, prematurity | Ferrous sulfate 3–6 mg/kg/day | Mentzer index, treat 3 months post-Hb |
This covers all 11 topics in depth from a pediatrics/neonatology perspective. Let me know which topic you'd like to explore further, practice with MCQs, or have condensed into a one-page revision sheet.